펜니들 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 바늘 길이별, 치료법별, 지역별, 부문별 예측(2025-2030년)

Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard Needles, Safety Needles), By Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-Peptide-1), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,287,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,679,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,465,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

펜니들 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 펜니들 시장 규모는 2025년부터 2030년까지 10.1%의 CAGR을 기록하여 2030년에는 78억 달러에 달할 것으로 추정됩니다.

당뇨병 유병률의 증가는 펜니들 시장이 크게 성장하는 주요 이유입니다. 국립 의학 도서관에 따르면, 2023년 당뇨병 환자 수는 151만 명 증가할 것으로 예상되며, 이는 주로 인구 고령화에 기인합니다. 이러한 전 세계 당뇨병의 높은 유병률은 펜니들 수요의 증가로 이어지고 있습니다. 당뇨병 환자들은 쉽게 구할 수 있는 주사 펜형 기구를 사용하는 것이 일반적입니다.

또한, 비만은 당뇨병의 중요한 원인입니다. 비만인 사람은 제2형 당뇨병을 앓고 있는 경우가 많으며, 목표 시장에서 가장 높은 수익 기여도를 보이는 사람들 중 하나입니다. 따라서 제 2형 당뇨병 환자는 펜니들 제조업체의 공통적인 타겟 인구입니다.

기술 발전의 증가 또한 시장 성장을 촉진할 것으로 예상됩니다. 펜 니들은 편안하고 간편한 인슐린 전달 모드를 가능하게 합니다. 이러한 장치는 기술적으로 진보되어 주사기 및 바이알에 비해 우수한 대체 약물전달 방법을 제공합니다. 예를 들어, Becton, Dickinson, and Company는 BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology를 출시했습니다.

펜니들 시장 보고서 하이라이트

• 제품별로 보면 안전침에 비해 비용 효율적인 바늘을 사용할 수 있기 때문에 표준 부문이 2024년 시장을 장악했습니다.
• 안전 펜 바늘은 지속적인 기술 발전으로 인해 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다.
• 바늘 길이 중 5mm 크기의 펜니들 부문은 피하 주사를 위한 편안함과 효과의 최적의 균형으로 인해 2024년 가장 큰 점유율을 차지했습니다.
• 바늘 길이 4mm는 짧은 길이로 인해 예측 기간 동안 매력적인 CAGR을 보일 것으로 예상됩니다.
• 인슐린 치료는 당뇨병 환자들 사이에서 인슐린 자가 투여에 대한 인식이 높아지면서 2024년 가장 큰 시장 점유율을 차지했습니다.
• 2024년 펜니들 시장은 유럽이 주도했으며, 유럽 지역의 높은 당뇨병 유병률로 인해 북미가 그 뒤를 이었습니다.
• 아시아태평양은 간편한 약물전달에 대한 당뇨병 환자의 인식 수준이 높아짐에 따라 예측 기간 동안 큰 CAGR을 보일 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 펜니들 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 펜니들 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 펜니들 시장 : 제품 추정·동향 분석

• 부문 대시보드
• 펜니들 시장 : 제품 변동 분석
• 제품별 펜니들 시장 전망
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 표준 펜니들
• 안전 펜니들

제5장 펜니들 시장 : 바늘 길이 추정·동향 분석

• 부문 대시보드
• 펜니들 시장 : 바늘 길이 변동 분석
• 바늘 길이별 펜니들 시장 전망
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 4mm
• 5mm
• 6mm
• 8mm
• 10mm
• 12mm

제6장 펜니들 시장 : 치료법 추정·동향 분석

• 부문 대시보드
• 펜니들 시장 : 치료법 변동 분석
• 치료법별 펜니들 시장 전망
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 인슐린
• 글루카곤 유사 펩티드-1
• 성장호르몬

제7장 펜니들 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 지역별 펜니들 시장 변동 분석
• 펜니들 시장 : 지역 추정·동향 분석, 2018-2030년
• 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
  • 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
  • 라틴아메리카
  • 브라질
  • 아르헨티나
  • 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출 기업 분류
• 주요 기업 개요
  • Novo Nordisk A/S
  • BD
  • Terumo Corp.
  • . Owen Mumford Ltd.
  • Ypsomed
  • B. Braun Melsungen AG
  • . HTL-STREFA
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Artsana SpA

ksm

영문 목차

영문목차

Pen Needles Market Growth & Trends:

The global pen needles market size is estimated to reach USD 7.8 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of diabetes is the primary reason for the significant growth of the pen needles market. According to the National Library of Medicine, the number of people with diabetes is expected to climb by 1.51 million in 2023, owing primarily to the ageing population. Such high prevalence of diabetes across the globe has led to rising demand for pen needles. Patients suffering from diabetes commonly use injectable pen devices, which help in easy drug delivery.

In addition, obesity is a significant cause of diabetes. Obese people often suffer from type 2 diabetes, which makes them one of the highest revenue contributors to the target market. Thus, people with type 2 diabetes are the common target population for companies manufacturing pen needles.

Rising technological advancements is also expected to drive the market growth. Pen needles allow comfort and easy mode of insulin delivery. These devices are technologically advanced and provide a superior alternative drug delivery method in comparison to syringes and vials. For instance, Becton, Dickinson, and Company launched BD Ultra-Fine Nano 4mm Pen Needles with Easy Flow Technology, which will enable diabetic patients with easy adherence to insulin therapy regimens.

Pen Needles Market Report Highlights:

• By product, the standard segment dominated the market in 2024, due to the availability of cost-effective needles as compared to safety needles.
• Safety pen needles are anticipated to showcase lucrative growth over the forecast period due to the continuous technological advancements.
• Amongst the needle lengths, 5 mm-sized pen needles segment held the largest share in 2024, due to its optimal balance of comfort and effectiveness for subcutaneous injections.
• Needle length of 4mm are expected to witness attractive CAGR over the forecast period owing to its short length.
• Insulin therapy accounted for the largest market share in 2024, due to rising awareness regarding self-administration of insulin amongst the diabetic patients.
• Europe dominated the pen needles market in 2024, followed by North America owing to the high prevalence of diabetes in the European region.
• Asia Pacific region is anticipated to exhibit the significant CAGR over the forecast period, owing to the rising awareness levels amongst the diabetic population regarding easy drug delivery.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Needle Length
  • 1.2.3. Therapy
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Needle length outlook
  • 2.2.3. Therapy outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pen Needles Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of diabetes
    • 3.2.1.2. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Preference for alternative drug delivery method
    • 3.2.2.2. Lack of skilled professionals
• 3.3. Pen Needles Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pen Needles Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pen Needles Market: Product Movement Analysis
• 4.3. Pen Needles Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Standard Pen Needles
  • 4.5.1. Standard Pen Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Safety Pen Needles
  • 4.6.1. Safety Pen Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pen Needles Market: Needle Length Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pen Needles Market: Needle Length Movement Analysis
• 5.3. Pen Needles Market by Needle Length Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. 4mm
  • 5.5.1. 4mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. 5mm
  • 5.6.1. 5mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. 6mm
  • 5.7.1. 6mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. 8mm
  • 5.8.1. 8mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. 10mm
  • 5.9.1. 10mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. 12mm
  • 5.10.1. 12mm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pen Needles Market: Therapy Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pen Needles Market: Therapy Movement Analysis
• 6.3. Pen Needles Market by Therapy Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Insulin
  • 6.5.1. Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Glucagon-Like-Peptide-1
  • 6.6.1. Glucagon-Like-Peptide-1 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Growth Hormone
  • 6.7.1. Growth Hormone Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pen Needles Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Pen Needles Market Movement Analysis
• 7.3. Pen Needles Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1 Key Country Dynamics
    • 7.5.7.2 Competitive Scenario
    • 7.5.7.3 Regulatory Framework
    • 7.5.7.4 Reimbursement scenario
    • 7.5.7.5 UK Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1 Key Country Dynamics
    • 7.5.8.2 Competitive Scenario
    • 7.5.8.3 Regulatory Framework
    • 7.5.8.4 Reimbursement scenario
    • 7.5.8.5 Germany Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1 Key Country Dynamics
    • 7.5.9.2 Competitive Scenario
    • 7.5.9.3 Regulatory Framework
    • 7.5.9.4 Reimbursement scenario
    • 7.5.9.5 France Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1 Key Country Dynamics
    • 7.5.10.2 Competitive Scenario
    • 7.5.10.3 Regulatory Framework
    • 7.5.10.4 Reimbursement scenario
    • 7.5.10.5 Italy Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1 Key Country Dynamics
    • 7.5.11.2 Competitive Scenario
    • 7.5.11.3 Regulatory Framework
    • 7.5.11.4 Reimbursement scenario
    • 7.5.11.5 Spain Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1 Key Country Dynamics
    • 7.5.12.2 Competitive Scenario
    • 7.5.12.3 Regulatory Framework
    • 7.5.12.4 Reimbursement scenario
    • 7.5.12.5 Denmark Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1 Key Country Dynamics
    • 7.5.13.2 Competitive Scenario
    • 7.5.13.3 Regulatory Framework
    • 7.5.13.4 Reimbursement scenario
    • 7.5.13.5 Sweden Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1 Key Country Dynamics
    • 7.5.14.2 Competitive Scenario
    • 7.5.14.3 Regulatory Framework
    • 7.5.14.4 Reimbursement scenario
    • 7.5.14.5 Norway Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.15. Asia Pacific
  • 7.5.16. Asia Pacific Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.17. Japan
    • 7.5.17.1 Key Country Dynamics
    • 7.5.17.2 Competitive Scenario
    • 7.5.17.3 Regulatory Framework
    • 7.5.17.4 Reimbursement scenario
    • 7.5.17.5 Japan Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.18. China
    • 7.5.18.1 Key Country Dynamics
    • 7.5.18.2 Competitive Scenario
    • 7.5.18.3 Regulatory Framework
    • 7.5.18.4 Reimbursement scenario
    • 7.5.18.5 China Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.19. India
    • 7.5.19.1 Key Country Dynamics
    • 7.5.19.2 Competitive Scenario
    • 7.5.19.3 Regulatory Framework
    • 7.5.19.4 Reimbursement scenario
    • 7.5.19.5 India Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.20. South Korea
    • 7.5.20.1 Key Country Dynamics
    • 7.5.20.2 Competitive Scenario
    • 7.5.20.3 Regulatory Framework
    • 7.5.20.4 Reimbursement scenario
    • 7.5.20.5 South Korea Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.21. Australia
    • 7.5.21.1 Key Country Dynamics
    • 7.5.21.2 Competitive Scenario
    • 7.5.21.3 Regulatory Framework
    • 7.5.21.4 Reimbursement scenario
    • 7.5.21.5 Australia Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.22. Thailand
    • 7.5.22.1 Key Country Dynamics
    • 7.5.22.2 Competitive Scenario
    • 7.5.22.3 Regulatory Framework
    • 7.5.22.4 Reimbursement scenario
    • 7.5.22.5 Thailand Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.23. Latin America
  • 7.5.24. Latin America Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.25. Brazil
    • 7.5.25.1 Key Country Dynamics
    • 7.5.25.2 Competitive Scenario
    • 7.5.25.3 Regulatory Framework
    • 7.5.25.4 Reimbursement scenario
    • 7.5.25.5 Brazil Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.26. Argentina
    • 7.5.26.1 Key Country Dynamics
    • 7.5.26.2 Competitive Scenario
    • 7.5.26.3 Regulatory Framework
    • 7.5.26.4 Reimbursement scenario
    • 7.5.26.5 Argentina Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.27. Middle East & Africa
  • 7.5.28. Middle East & Africa Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.29. South Africa
    • 7.5.29.1 Key Country Dynamics
    • 7.5.29.2 Competitive Scenario
    • 7.5.29.3 Regulatory Framework
    • 7.5.29.4 Reimbursement scenario
    • 7.5.29.5 South Africa Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.30. Saudi Arabia
    • 7.5.30.1 Key Country Dynamics
    • 7.5.30.2 Competitive Scenario
    • 7.5.30.3 Regulatory Framework
    • 7.5.30.4 Reimbursement scenario
    • 7.5.30.5 Saudi Arabia Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.31. UAE
    • 7.5.31.1 Key Country Dynamics
    • 7.5.31.2 Competitive Scenario
    • 7.5.31.3 Regulatory Framework
    • 7.5.31.4 Reimbursement scenario
    • 7.5.31.5 UAE Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.32. Kuwait
    • 7.5.32.1 Key Country Dynamics
    • 7.5.32.2 Competitive Scenario
    • 7.5.32.3 Regulatory Framework
    • 7.5.32.4 Reimbursement scenario
    • 7.5.32.5 Kuwait Pen Needles Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Novo Nordisk A/S
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. BD
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Terumo Corp.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. . Owen Mumford Ltd.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Ypsomed
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. B. Braun Melsungen AG
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. . HTL-STREFA
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. UltiMed, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Allison Medical, Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Artsana S.p.A.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료